These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10980829)

  • 1. Fibrinogen and coronary risk.
    Koenig W
    Curr Cardiol Rep; 1999 Jul; 1(2):112-8. PubMed ID: 10980829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrin(ogen) in cardiovascular disease: an update.
    Koenig W
    Thromb Haemost; 2003 Apr; 89(4):601-9. PubMed ID: 12669113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fibrinogen. Cardiovascular risk factor or marker?].
    Canseco-Avila LM; Jerjes-Sánchez C; Ortiz-López R; Rojas-Martínez A; Guzmán-Ramírez D
    Arch Cardiol Mex; 2006; 76 Suppl 4():S158-72. PubMed ID: 17469344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen and cardiovascular risk.
    Ernst E; Koenig W
    Vasc Med; 1997; 2(2):115-25. PubMed ID: 9546953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen after coronary angioplasty as a risk factor for restenosis.
    Montalescot G; Ankri A; Vicaut E; Drobinski G; Grosgogeat Y; Thomas D
    Circulation; 1995 Jul; 92(1):31-8. PubMed ID: 7788913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of the cardiovascular risk factor fibrinogen in secondary prevention].
    Baller D; Gleichmann U; Miche E; Mannebach H; Seggewiss H
    Versicherungsmedizin; 1995 Apr; 47(2):55-60. PubMed ID: 7762117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen: its emerging role as a cardiovascular risk factor.
    Ernst E
    Angiology; 1994 Feb; 45(2):87-93. PubMed ID: 8129195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen--marker or mediator of vascular disease?
    Reinhart WH
    Vasc Med; 2003; 8(3):211-6. PubMed ID: 14989564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of plasma fibrinogen levels with coronary artery disease, smoking and inflammatory markers.
    de Maat MP; Pietersma A; Kofflard M; Sluiter W; Kluft C
    Atherosclerosis; 1996 Apr; 121(2):185-91. PubMed ID: 9125293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin generation markers and coronary heart disease risk factors in a Polish population sample.
    Musiał J; Pajak A; Undas A; Kawalec E; Topór-Madry R; Pazucha T; Grzywacz M; Szczeklik A
    Thromb Haemost; 1997 Apr; 77(4):697-700. PubMed ID: 9134645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinogen as a cardiovascular risk factor--interrelationship with infections and inflammation.
    Ernst E
    Eur Heart J; 1993 Dec; 14 Suppl K():82-7. PubMed ID: 8131795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased platelet activation and fibrinogen in Asian Indians. Potential implications for coronary risk.
    Markovitz JH; Kulkarni K; Goldschmidt-Clermont P; Kiefe CI; Rustagi P; Sekar P; Nanda N
    Eur Heart J; 1998 May; 19(5):720-6. PubMed ID: 9717004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fibrinogen, a vascular risk factor].
    Caen JP; Soria J; Collet JP; Soria C
    Bull Acad Natl Med; 1993 Nov; 177(8):1433-41; discussion 1441-4. PubMed ID: 8193948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen: its role in the hemostatic regulation in atherosclerosis.
    Eber B; Schumacher M
    Semin Thromb Hemost; 1993; 19(2):104-7. PubMed ID: 8356454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study.
    Saito I; Folsom AR; Brancati FL; Duncan BB; Chambless LE; McGovern PG
    Ann Intern Med; 2000 Jul; 133(2):81-91. PubMed ID: 10896647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic influences on fibrinogen, tissue plasminogen activator-antigen and von Willebrand factor in males and females.
    de Lange M; de Geus EJ; Kluft C; Meijer P; van Doornen LJ; Boomsma DI; Snieder H
    Thromb Haemost; 2006 Mar; 95(3):414-9. PubMed ID: 16525567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain.
    Heinrich J; Schulte H; Schönfeld R; Köhler E; Assmann G
    Thromb Haemost; 1995 Mar; 73(3):374-9. PubMed ID: 7667818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of tissue plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen with coronary artery disease in South Indian male subjects.
    Deepa R; Velmurugan K; Saravanan G; Dwarakanath V; Agarwal S; Mohan V
    J Assoc Physicians India; 2002 Jul; 50():901-6. PubMed ID: 12126344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemostatic factors and lipoprotein (a) in three geographical areas in Finland: the Finrisk Haemostasis Study.
    Salomaa VV; Rasi VP; Vahtera EM; Pekkanen J; Pursiainen M; Jauhiainen M; Vartiainen E; Ehnholm CP; Myllylä G
    J Cardiovasc Risk; 1994 Oct; 1(3):241-8. PubMed ID: 7621304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of plasma fibrinogen in coronary arterial disease: marker or causative risk factor for arterial thrombosis?
    Kovacs IB; Ratnatunga CP; Ridler CD; Görög P; Edmondson SJ; Rees GM
    Int J Cardiol; 1992 Apr; 35(1):57-64. PubMed ID: 1563880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.